TNF-α inhibitors, used for the treatment of inflammatory autoimmune diseases, for instance, in RA, ankylosing spondylitis, Crohn’s disease, inflammatory bowel disease, Behcet’s disease, psoriasis, psoriatic arthritis, and juvenile arthritis, may exacerbate MRONJ. This evidence concerns the gene TNF and Crohn disease.